Kintor Pharmaceutical Limited (KNTPF)
OTCMKTS · Delayed Price · Currency is USD
0.3316
0.00 (0.00%)
At close: Feb 5, 2026
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of $176.15 million as of February 12, 2026. Its market cap has increased by 252.08% in one year.
Market Cap
176.15M
Enterprise Value
180.99M
Revenue
1.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.33
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 1.02B to 176.15M, a decrease of -82.80%. That is a compound annual growth rate of -26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 176.15M | 41.74% |
| Dec 31, 2025 | 124.28M | 129.85% |
| Dec 31, 2024 | 54.07M | -42.09% |
| Dec 29, 2023 | 93.37M | -83.48% |
| Dec 30, 2022 | 565.31M | -7.54% |
| Dec 31, 2021 | 611.38M | 22.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |